Dr Oscar T Cassity, MD | |
340 Exchange Blvd, Bethlehem, GA 30620-1759 | |
(800) 532-6151 | |
(706) 354-5769 |
Full Name | Dr Oscar T Cassity |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 340 Exchange Blvd, Bethlehem, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386626059 | NPI | - | NPPES |
000405083A | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 29152 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Oscar T Cassity, MD 1010 Village Dr, Watkinsville, GA 30677-6004 Ph: (706) 475-4350 | Dr Oscar T Cassity, MD 340 Exchange Blvd, Bethlehem, GA 30620-1759 Ph: (800) 532-6151 |
News Archive
The hormone leptin, typically associated with body weight regulation, works within the central nervous system (CNS) to aid the immune system's defense against sepsis, researchers say.
With acute appendicitis ranking among the nation's most common acute surgical emergencies, researchers studied the relatively routine use of post-operative antibiotics in complicated cases and found that they didn't reduce infections after surgery. They also found that patients who received post-operative antibiotics remained in the hospital up to one day longer than similar patients who had not received antibiotics.
For years, science has generally considered the phosphorylation of proteins - the insertion of a phosphorous group into a protein that turns it on or off - as perhaps the factor regulating a range of cellular processes from cell metabolism to programmed cell death. Now, scientists from the Florida campus of The Scripps Research Institute have identified the importance of a novel protein-regulating mechanism - called sulfenylation - that is similar to phosphorylation and may, in fact, open up opportunities to develop new types of drugs for diseases such as cancer.
Dana-Farber Cancer Institute investigators report they have discovered a type of immune antibody that can rapidly evolve to neutralize a wide array of influenza virus strains - including those the body hasn't yet encountered.
› Verified 2 days ago